SiRNA mediated RPSA knock-down resulted in a significant decrease of viability in different cancer cell lines, such as BC and oesophageal cancer cells [51], pancreatic cancer and neuroblastoma cells [52], melanoma [53] and CRC cells [54]. Here, RPSA is linked to cancer.